Marcin F Osuchowski
Overview
Explore the profile of Marcin F Osuchowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azizian-Farsani F, Weixelbaumer K, Mascher D, Klang A, Hogler S, Dinhopl N, et al.
Intensive Care Med Exp
. 2024 Nov;
12(1):96.
PMID: 39497013
Background: Septic encephalopathy is frequent but its pathophysiology is enigmatic. We studied expression of neurotransmitters, inflammation and integrity of the blood-brain barrier (BBB) in several brain regions during abdominal sepsis....
2.
Zipperle J, Vock L, Fritsch G, Grillari J, Osuchowski M, Holnthoner W, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456945
Extracorporeal membrane oxygenation (ECMO) provides critical support for patients with severe cardiopulmonary dysfunction. Unfractionated heparin (UFH) is used for anticoagulation to maintain circuit patency and avoid thrombotic complications, but it...
3.
Llitjos J, Carrol E, Osuchowski M, Bonneville M, Scicluna B, Payen D, et al.
Crit Care
. 2024 Jul;
28(1):238.
PMID: 39003476
Implementation of biomarkers in sepsis and septic shock in emergency situations, remains highly challenging. This viewpoint arose from a public-private 3-day workshop aiming to facilitate the transition of sepsis biomarkers...
4.
Zipperle J, Oesterreicher J, Hackl M, Krammer T, Thumfart H, Bobbili M, et al.
Intensive Care Med Exp
. 2023 Nov;
11(1):85.
PMID: 38032394
Extracellular vesicles (EVs) represent nanometer-sized, subcellular spheres, that are released from almost any cell type and carry a wide variety of biologically relevant cargo. In severe cases of coronavirus disease...
5.
Cavaillon J, Osuchowski M
J Intensive Med
. 2023 Mar;
1(1):4-13.
PMID: 36943823
Humanity has regularly faced the threat of epidemics and pandemics over the course of history. Successful attempts to protect populations were initially made with the development of new vaccines, such...
6.
Remick D, Szabo A, Juffermans N, Osuchowski M
Shock
. 2023 Mar;
59(3S Suppl 1):2-5.
PMID: 36867755
No abstract available.
7.
Herminghaus A, Osuchowski M
EBioMedicine
. 2022 Dec;
86:104355.
PMID: 36470836
No abstract available.
8.
Winkler M, Osuchowski M, Payen D, Torres A, Dickel S, Skirecki T
Crit Care
. 2022 Oct;
26(1):308.
PMID: 36209188
The 40-year-old experience with glucocorticosteroids (GCs) in the context of severe infections is complex and troublesome. Recently, however, a clear indication for GCs in severe COVID-19 has been established. This...
9.
Yao Y, Osuchowski M, Wang J, Pan Z
Front Immunol
. 2022 Jan;
12:822068.
PMID: 34975929
No abstract available.
10.
Oberladstatter D, Schlimp C, Zipperle J, Osuchowski M, Voelckel W, Grottke O, et al.
J Clin Med
. 2021 Aug;
10(16).
PMID: 34441771
Specific antagonists have been developed for the reversal of direct oral anticoagulants (DOAC). We investigated the impact of these reversal agents on the plasma concentration and visco-elastic test results of...